NCT04655521 Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2 Status COMPLETED Phase N/A
NCT04654442 Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample Status COMPLETED Phase N/A
NCT04654325 Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients Status TERMINATED Phase NA
NCT04652102 A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older Status COMPLETED Phase PHASE2/PHASE3
NCT04649151 A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 Status COMPLETED Phase PHASE2/PHASE3
NCT04649021 Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population Status COMPLETED Phase PHASE2
NCT04639375 Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) Status UNKNOWN Phase PHASE4
NCT04627675 CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) Status TERMINATED Phase PHASE1
NCT04620798 Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students Status COMPLETED Phase NA
NCT04619693 Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia Status TERMINATED Phase N/A
NCT04619407 Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers Status COMPLETED Phase N/A
NCT04613310 PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19) Status COMPLETED Phase NA
NCT04608214 Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19) Status COMPLETED Phase PHASE2
NCT04592549 Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19 Status COMPLETED Phase PHASE1
NCT04591184 A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults Status COMPLETED Phase PHASE1/PHASE2
NCT04565249 Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19 Status TERMINATED Phase PHASE2